IsoPlexis Competitors and Similar CompaniesClear all
IsoPlexis's competitors and similar companies include Biocartis, GenMark Diagnostics and Hardy Diagnostics.
 IsoPlexis IsoPlexis is a company that develops a diagnostic platform for immunology research and therapeutic development. |  Biocartis Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. |  Hardy Diagnostics Hardy Diagnostics is a company that produces products for the detection of microorganisms. | ||
Founding Date | Founding Date 2013 | Founding Date 2007 | Founding Date 2010 | Founding Date 2004 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Branford, US HQ Shanghai, CN Birmingham, GB | Locations Jersey City, US HQ Meadowbrook, AU Mechelen, BE Sofia, BG Huechuraba, CL Zagreb, HR Espoo, FI see more | Locations Carlsbad, US HQ Carlsbad, US | Locations Santa Maria, US HQ |
Employees | Employees 29037% decrease | Employees 52614% increase | Employees 4402% increase | Employees 230 |
Financial | ||||
Revenue (est.) | Revenue (est.) $16.8m (FY, 2022) | Revenue (est.) €47.4m (FY, 2023) | Revenue (est.) $171.6m (FY, 2020) | Revenue (est.) N/A |
Cost of goods | Cost of goods $17.7m (FY, 2022) | Cost of goods €12.4m (FY, 2023) | Cost of goods $103.6m (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit ($925k) (FY, 2022) | Gross profit €35.3m (FY, 2023) | Gross profit $67.9m (FY, 2020) | Gross profit N/A |
Net income | Net income ($106m) (FY, 2022) | Net income €18.4m (FY, 2023) | Net income ($18.6m) (FY, 2020) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 171.8m | Total funding raised $ 321.2m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Biocartis
HQ
Jersey City, US
Employees
526↑ 14% increase
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
View company
GenMark Diagnostics
HQ
Carlsbad, US
GenMark Diagnostics is a provider of multiplex molecular diagnostic solutions.
View companyHardy Diagnostics
HQ
Santa Maria, US
Employees
230
Hardy Diagnostics is a company that produces products for the detection of microorganisms.
View company